Results 21 to 30 of about 2,572,587 (193)

Insulin and heparin challenge tests are useful for choosing an optimal insulin regimen in a case of subcutaneous insulin resistance

Journal of Diabetes Investigation, 2020
A 38‐year‐old woman with type 1 diabetes, whose fasting plasma glucose levels were >500 mg/dL under 176 U/day of subcutaneous insulin injection, was admitted to Nippon Medical School Hospital, Tokyo, Japan.
Yuko Nakamura, Mototsugu Nagao, Shunsuke Kobayashi, Takeshi Oba, Yuki Shuto, Izumi Fukuda, Shinichi Oikawa, Hitoshi Sugihara   +7 more
doaj   +1 more source

Continuous Subcutaneous Insulin Infusion [PDF]

Archives of Internal Medicine, 2001
A tremendous amount of data suggest that near-normal glycemic control prevents or delays complications of diabetes, which has led to a dramatic increase in continuous subcutaneous insulin infusion (CSII) or insulin pump use. In this article, the data supporting CSII in type 1 diabetes is reviewed, and the advantages and disadvantages of CSII are ...
M J, Lenhard, G D, Reeves
openaire   +2 more sources

The 5th International Conference on Advanced Technologies Treatments for Diabetes (ATTD 2012),2012 February 8-11, Barcelona (Spain)

Сахарный диабет, 2012
Пятая ежегодная международная конференция ATTD (Advanced Technologies & Treatment for Diabetes) прошла 8?11 февраля 2012 года в Испании (г. Барселона). Данное мероприятие организуется ежегодно под руководством проф.
Yury Ivanovich Filippov, Lyudmila Ibragimovna Ibragimova, Ekaterina Alekseevna Shestakova, Olga Yur'evna Sukhareva   +3 more
doaj   +1 more source

INTERPRETATION OF DATA IN THE CONTINUOUS MONITORING OF GLUCOSE. RECOMMENDATIONS FOR THE INDICATION

Revista de la Sociedad Argentina de Diabetes, 2020
Glycemic monitoring is a fundamental pillar in the treatment of the patient with diabetes. Epidemiological studies such as the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT / EDIC ...
Gabriela Rovira
doaj   +1 more source

Insulin Infusion Set: The Achilles Heel of Continuous Subcutaneous Insulin Infusion [PDF]

Journal of Diabetes Science and Technology, 2012
Continuous subcutaneous insulin infusion from an insulin pump depends on reliable transfer of the pumped insulin to the subcutaneous insulin depot by means of an insulin infusion set (IIS). Despite their widespread use, the published knowledge about IISs and related issues regarding the impact of placement and wear time on insulin absorption/insulin ...
Lutz, Heinemann, Lars, Krinelke
openaire   +2 more sources

Insulin pump therapy in transient neonatal diabetes mellitus [PDF]

Annals of Pediatric Endocrinology & Metabolism, 2013
Neonatal diabetes mellitus (NDM) is a rare disease requiring insulin treatment. Its treatment is primarily focused on maintaining adequate glycemic control and avoiding hypoglycemia.
Joong Heum Park, Jeong Hee Kang, Kyu-Hyung Lee, Nam-Hyo Kim, Han-Wook Yoo, Dae-Yeol Lee, Eun-Gyong Yoo   +6 more
doaj   +1 more source

Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review

BioMedical Engineering OnLine, 2019
For individuals affected by Type 1 diabetes (T1D), a chronic disease in which the pancreas does not produce any insulin, maintaining the blood glucose (BG) concentration as much as possible within the safety range (70–180 mg/dl) allows avoiding short ...
Martina Vettoretti, Andrea Facchinetti
doaj   +1 more source

Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes : systematic review and economic evaluation [PDF]

, 2010
Based on the totality of evidence, using observational studies to supplement the limited data from randomised trials against best MDI, CSII provides some advantages over MDI in T1DM for both children and adults.
P Royle, Snaith, Ailsa, N Waugh, L Robertson, A Snaith, McIntyre, Linda, A Greene, Cummins, E. (Ewen), E Cummins, L McIntyre, Waugh, Norman, Robertson, L., Royle, Pamela, Greene, A.   +13 more
core   +1 more source

A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion

, 2009
Continuous intraperitoneal insulin infusion (CIPII) with the DiaPort system using regular insulin was compared to continuous subcutaneous insulin infusion (CSII) using insulin Lispro, to investigate the frequency of hypoglycemia, blood glucose control ...
Geelhoed-Duijvestijn, P H L M, Hoogma, R, Frei, T., Renard, E., Klein, E., Diglas, J, Kessler, L, Hoogma, R., Kessler, L., Melki, V., Klein, E, Brun, J.-M., Renseigné, Non, Diglas, J., Liebl, A, Frei, T, Schaepelynck-Bélicar, P., Liebl, A., Geelhoed-Duijvestijn, P. H. L. M., Renard, E, Diem, P., Diem, P, Brun, J-M, Schaepelynck-Bélicar, P, Melki, V, Diem, Peter, R. Hoogma, V. Melki, P. Schaepelynck-Bélicar, L. Kessler, A. Liebl, P. Diem, P. H. L. M. Geelhoed-Duijvestijn, J.-M. Brun, E. Klein, E. Renard, null null, T. Frei, J. Diglas   +38 more
core   +1 more source

Insulin resistance syndrome in a patient with limited cutaneous systemic sclerosis and type 2 diabetes and its response to plasma exchange, immunosuppression, and the Minimed® 780G continuous subcutaneous insulin infusion hybrid system

Revista Colombiana de Endocrinología, Diabetes y Metabolismo
Introduction: Type B insulin resistance syndrome (TBIRS) is an immune-mediated disorder characterized by severe acanthosis nigricans and difficult-to-control diabetes mellitus. This condition represents a complex clinical challenge.
Fabio Nelson Figueroa Agudelo, Víctor Manuel Blanco Pico, Andrés Octavio García Trujillo, Jorge Wilmar Tejada Marín, Karen Milena Feriz Bonelo, Guillermo Edinson Guzmán Gómez, Carlos Alberto Cañas   +6 more
doaj   +1 more source